iSpecimen Inc. Files 8-K Report

Ticker: ISPC · Form: 8-K · Filed: 2025-08-07T00:00:00.000Z

Sentiment: neutral

Topics: 8-k, sec-filing, regulation-fd

TL;DR

iSpecimen filed an 8-K, looks like standard reporting, no major news.

AI Summary

On August 7, 2025, iSpecimen Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits, with no specific new financial figures or material events detailed in the provided text.

Why It Matters

This filing indicates routine corporate reporting by iSpecimen Inc. to the SEC, providing transparency on their regulatory compliance and financial disclosures.

Risk Assessment

Risk Level: low — The filing appears to be routine and does not disclose any new material events, financial changes, or risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for iSpecimen Inc.?

The filing is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, primarily concerning Regulation FD Disclosure and Financial Statements and Exhibits.

On what date was the earliest event reported in this filing?

The date of the earliest event reported is August 7, 2025.

In which state is iSpecimen Inc. incorporated?

iSpecimen Inc. is incorporated in Delaware.

What is the principal executive office address for iSpecimen Inc.?

The address of the principal executive offices is 8 Cabot Road, Suite 1800, Woburn, MA 01801.

Does this filing indicate any specific new financial results or material events?

The provided text of the filing does not detail specific new financial results or material events; it focuses on the report type and company information.

From the Filing

0001213900-25-073069.txt : 20250807 0001213900-25-073069.hdr.sgml : 20250807 20250807160532 ACCESSION NUMBER: 0001213900-25-073069 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250807 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250807 DATE AS OF CHANGE: 20250807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 251193886 BUSINESS ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 8-K 1 ea0252182-8k_ispecimen.htm CURRENT REPORT false 0001558569 0001558569 2025-08-07 2025-08-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): August 7, 2025   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   8 Cabot Road , Suite 1800 Woburn , MA 01801 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐           Item 7.01 Regulation FD Disclosure.   On August 7, 2025, iSpecimen Inc. (the “Company”) issued a press release announcing a major strategic initiative aimed at integrating digital assets into its business model. The Company is looking to build an up to $200 million corporate treasury reserve built around the Solana blockchain ecosystem. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.   The information in this Item 7.01 and Exhibit 99.1 shall not be deemed “filed” for pu

View on Read The Filing